XFOR insider trading
See X4 Pharmaceuticals (XFOR) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.
Insider trades
| Insider | Role | Trade | Traded | Filed | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|
| Craig Adam R | Executive Chairman, Director | Buy | Oct 16, 2026 | Oct 19, 2026 | 4,600 | $2.58 | $11.88K | Filing |
| KIRSKE DAVID | Chief Financial Officer | Sell | Oct 1, 2026 | Oct 5, 2026 | 11,767 | $2.86 | $33.66K | Filing |
| Volpone John | President | Sell | Aug 12, 2026 | Aug 13, 2026 | 24,576 | $4.44 | $109.12K | Filing |
| Craig Adam R | Executive Chairman, Director | Sell | Aug 12, 2026 | Aug 13, 2026 | 47,436 | $4.44 | $210.62K | Filing |
| KIRSKE DAVID | Chief Financial Officer | Sell | Jun 30, 2026 | Jul 1, 2026 | 8,543 | $4.26 | $36.39K | Filing |
| KIRSKE DAVID | Chief Financial Officer | Sell | May 12, 2026 | May 13, 2026 | 16,961 | $4.29 | $72.82K | Filing |
| Craig Adam R | Executive Chairman, Director | Buy | Oct 23, 2025 | Oct 27, 2025 | 86,206 | $2.90 | $250.00K | Filing |
| Baldry Mark | Chief Commercial Officer | Buy | May 17, 2024 | Feb 14, 2025 | 21,646 | $0.68 | $14.65K | Filing |
| Baldry Mark | Chief Commercial Officer | Buy | Nov 15, 2024 | Feb 14, 2025 | 13,404 | $0.34 | $4.60K | Filing |
| Ragan Paula | President and CEO, Director | Sell | Jan 24, 2025 | Jan 27, 2025 | 76,473 | $0.45 | $34.72K | Filing |
| Mostafa Adam S. | Chief Financial Officer | Sell | Jan 24, 2025 | Jan 27, 2025 | 74,773 | $0.45 | $33.95K | Filing |
| Baldry Mark | Chief Commercial Officer | Sell | Jan 24, 2025 | Jan 27, 2025 | 29,159 | $0.45 | $13.24K | Filing |
| DiBiase Mary | Chief Operating Officer | Sell | Jan 24, 2025 | Jan 27, 2025 | 22,258 | $0.45 | $10.09K | Filing |
| Arbet-Engels Christophe | Chief Medical Officer | Sell | Jan 24, 2025 | Jan 27, 2025 | 11,624 | $0.45 | $5.28K | Filing |
| Ragan Paula | President and CEO, Director | Sell | Nov 15, 2024 | Nov 19, 2024 | 31,897 | $0.39 | $12.58K | Filing |